Anaxago

Anaxago is a French crowdfunding platform established in 2018, specializing in connecting innovative startups and investors. The company offers a unique, participative investment model that goes beyond financial support, fostering collaboration between entrepreneurs and investors. Anaxago meticulously selects and evaluates startups with a focus on innovation and growth potential, offering a curated selection to its investor community each month. Since its inception, Anaxago has gathered over 100,000 members and facilitated investments exceeding 130 million euros in more than 200 businesses across sectors such as health tech, real estate, and climate tech.

Alexandre Heraud

Partner

50 past transactions

Check & Visit

Series A in 2023
Check & Visit is a Rennes, France-based software company founded in 2017 that develops a real estate inventory platform to organize and carry out property inventories. The platform supports dematerialized inventories with photos and digital monitoring, offers inventory booking, and facilitates certified checkers to perform validated inventories. It serves property owners and real estate professionals, providing structured inventories with photo documentation and responsive customer support by email or phone, with the goal of converting inventory data into actionable insights and improving accuracy, efficiency, and client engagement.

Posos

Series A in 2022
Posos is a clinical decision support platform that enhances healthcare professionals' ability to make informed treatment choices by using AI-powered cross-referencing to contextualize drug information with individual patient data. It supports prescription management, analyzes regimens in real time, identifies potential iatrogenic risks, and offers personalized recommendations to improve safety and effectiveness across the patient journey.

CapHorn

Acquisition in 2022
CapHorn Invest, established in 2010, is a Paris-based venture capital firm focusing on climate and health technologies. It manages 180 million euros across two funds and has invested in over 20 companies. CapHorn primarily targets seed to Series B rounds, investing between 1 to 10 million euros in transformative technologies that combat climate change. Since 2020, it operates as a Club Deal under the financial structure of Anaxago.

Unkle

Series A in 2022
Unkle is an Insurtech startup based in Paris, France, focused on simplifying the rental process for both tenants and landlords. The company offers four primary insurance products: a renter guarantee, which allows Unkle to act as a guarantor for tenants for a fee; a landlord guarantee, which protects property owners against unpaid rent; home insurance; and owner insurance. By providing these services, Unkle aims to enhance rental applications and reduce the risks associated with renting, making it easier for tenants to find housing while offering landlords financial security.

PEP-Therapy

Series A in 2021
PEP-Therapy is a biotechnology company specializing in the development of innovative peptide-based therapies aimed at treating severe diseases, with a primary emphasis on cancer. The company focuses on creating Cell Penetrating and Interfering Peptides, which are designed for intracellular delivery of targeted treatments. These peptides effectively penetrate cell membranes to block crucial intracellular protein-protein interactions, thereby inhibiting important pathogenic mechanisms associated with various diseases. By harnessing the potential of these active compounds, PEP-Therapy aims to advance therapeutic options in oncology and beyond.

Xenothera

Series C in 2021
Xenothera is a biotechnology company that specializes in xenotherapy, focusing on the development of innovative immunological treatments. Utilizing a unique technological platform, Xenothera combines expertise in animal genetics with advanced immunology processes to create new therapeutic approaches for various medical conditions, including immunomodulation and infectious diseases. The company is particularly noted for its development of hyperimmune polyclonal sera, which represents a new generation of passive immunotherapy. By controlling the entire process—from the selection of immunogens to the purification of immunoglobulins—Xenothera is able to accelerate the development and market authorization of its therapies, thereby facilitating timely access to novel treatments for patients.

OCUS

Series B in 2021
OCUS empowers large corporations worldwide by harnessing visual content's power for business growth. It combines advanced technology with a community of over 30,000 creatives to deliver high-quality brand imagery at scale.

Imageens

Seed Round in 2021
Imageens is a technology company that specializes in developing an AI-based platform for the analysis of medical images, particularly in the field of cardiovascular care. The platform is designed to enhance the productivity of healthcare professionals by providing faster processing and more accurate reporting of medical images. It focuses on measuring arterial stiffness and flow biomarkers, which are critical indicators of cardiovascular health and significant predictors of cardiovascular mortality. By facilitating early detection and diagnosis of cardiovascular diseases, Imageens supports healthcare institutions, radiologists, cardiologists, and vascular surgeons in monitoring prevention strategies and making personalized treatment decisions. The company's innovative approach aims to improve the assessment of cardiovascular risk, ultimately contributing to better patient outcomes.

SweepBright

Venture Round in 2020
SweepBright NV, established in 2016 and headquartered in Antwerp, Belgium, develops a mobile application tailored for real estate agents and brokers. The SweepBright app streamlines real estate transactions by simplifying sales processes, saving time and costs. Key features include creating new listings on location, editing images, booking photographers, generating professional-looking plans of listings, automatically matching listings with leads, scheduling visits, and interacting with buyers and sellers. The application is designed for mobile usage and integrates seamlessly with third-party applications, enabling real estate agencies to enhance efficiency and deliver exceptional customer experiences.

Bulldozair

Series A in 2020
BulldozAIR is a construction project management platform designed to enhance collaboration between large corporations and their construction contractors. The platform allows users to assign remote technical instructions, visualize project progress, and automatically generate activity reports, facilitating effective communication between onsite teams and office personnel. Used by industry leaders in sectors such as real estate, energy, retail, transportation, infrastructure, and manufacturing, BulldozAIR serves notable clients including Carrefour, Total, Air Liquide, Vinci, Bouygues, Arkema, CHANEL, and SNCF. Headquartered in Station F, the world's largest startup incubator, BulldozAIR operates on an international scale, providing an innovative solution to streamline construction project management.

Osivax

Series B in 2020
Osivax develops immunotherapy vaccines designed to enhance the body's immune response against infectious diseases. Their vaccines aim to expedite uptake into dendritic cells and increase immunogenicity of natural proteins, triggering a more effective immune response, including CD8 T cell activation. This enables medical practitioners to treat patients with conditions such as cancer, influenza, malaria, and other infectious diseases.

Robocath

Series C in 2020
Robocath, founded in 2009 by Philippe Bencteux, MD, specializes in the design, development, and commercialization of robotic solutions for treating cardiovascular diseases. The company is a prominent player in the medical robotics industry, focusing on enhancing the safety and efficacy of medical procedures through innovative technology. Its flagship product, R-One™, is a robotic system specifically engineered for coronary angioplasty, optimizing safety and precision during interventions. R-One™ offers a unique open architecture that ensures compatibility with leading medical devices and catheterization laboratories, facilitating improved procedural conditions. Robocath aims to establish itself as a leader in vascular robotics while advancing the remote treatment of vascular emergencies, thereby ensuring optimal care pathways for patients.

upOwa

Equity Crowdfunding in 2019
upOwa is a social business that develops, deploys, and maintains innovative solar home systems in off-grid African communities. These systems provide affordable access to clean electricity, replacing traditional sources like kerosene lamps. By doing so, upOwa enables significant social and economic improvements at the community level while maintaining financial profitability and promoting environmental sustainability.

Happywait

Seed Round in 2019
Happywait is a digital platform that streamlines the real estate purchasing process by providing real-time updates on project development. Founded in 2015 and based in Rennes, France, the company aims to alleviate the frustrations faced by buyers and promoters due to the lengthy waiting periods—sometimes up to 24 months—between signing contracts and receiving properties. The platform facilitates effective communication between buyers and promoters through an internal messaging system, while also pushing relevant information to buyers. By digitizing the property purchase and sales processes, Happywait enhances operational efficiency, accelerates sales activities, and fosters better relationships with customers.

Posos

Seed Round in 2019
Posos is a clinical decision support platform that enhances healthcare professionals' ability to make informed treatment choices by using AI-powered cross-referencing to contextualize drug information with individual patient data. It supports prescription management, analyzes regimens in real time, identifies potential iatrogenic risks, and offers personalized recommendations to improve safety and effectiveness across the patient journey.

MeilleureCopro

Venture Round in 2019
MeilleureCopro is a real estate platform focused on reducing condominium fees while ensuring high service quality. The company collaborates with real estate developers, trustees, and union councils to optimize building expenses through a data-driven approach. By leveraging algorithms, MeilleureCopro offers free audits and comprehensive optimization plans for co-owners, analyzing condominium expenses and renegotiating contracts with service providers. This process not only lowers costs but also enhances occupant satisfaction. Additionally, MeilleureCopro serves as a valuable resource for service providers that align with its principles, contributing to improved living conditions for residents.

Smartrenting

Series A in 2019
Smartrenting, Inc. is a real estate agency based in Paris, France, with an additional office in Lyon. Founded in 2015, the company specializes in the subletting of apartments, providing a legal, free, and secure solution for property owners and tenants. Smartrenting offers an online platform that simplifies the renting process by managing the subletting of apartments during owners' absences. The company carefully selects future tenants and ensures that the property is returned in a clean and well-maintained condition. By facilitating efficient renting management, Smartrenting empowers travelers and property owners to navigate the housing market with ease.

upOwa

Series A in 2019
upOwa is a social business that develops, deploys, and maintains innovative solar home systems in off-grid African communities. These systems provide affordable access to clean electricity, replacing traditional sources like kerosene lamps. By doing so, upOwa enables significant social and economic improvements at the community level while maintaining financial profitability and promoting environmental sustainability.

Osivax

Series A in 2019
Osivax develops immunotherapy vaccines designed to enhance the body's immune response against infectious diseases. Their vaccines aim to expedite uptake into dendritic cells and increase immunogenicity of natural proteins, triggering a more effective immune response, including CD8 T cell activation. This enables medical practitioners to treat patients with conditions such as cancer, influenza, malaria, and other infectious diseases.

Innovorder

Venture Round in 2019
Founded in 2014, Innovorder specializes in digital solutions for the food service industry. Its comprehensive SaaS software suite enables deployment of new order channels, management of restaurant networks and points of sale, acceleration of order processing, optimization of production management, sales monitoring, and customer loyalty programs. Serving over 800 customers including KFC, Elior, and Compass Group, Innovorder employs more than 60 people and has raised over €10 million.

Acticor Biotech

Series B in 2018
Acticor Biotech SAS is a clinical-stage biopharmaceutical company based in Paris, France, founded in 2013. The company specializes in developing innovative therapeutic monoclonal antibodies aimed at treating acute thrombotic diseases, particularly focusing on acute ischemic stroke. Its lead product, Glenzocimab, is a humanized antibody designed to address the critical need for new therapeutic options in the management of stroke, a condition that affects millions globally each year and leads to significant mortality and disability. Currently, existing treatments for ischemic stroke have limited efficacy and reach, highlighting the urgent demand for more effective solutions. Acticor Biotech is dedicated to advancing its novel therapies to meet this pressing medical need.

Limonetik

Venture Round in 2018
Limonetik is a payment platform provider that specializes in addressing the complex payment needs of multichannel retailers, marketplaces, gig economy platforms, and business-to-business entities. Originally focused on processing and aggregating payment methods for online and offline use in Europe, the company has expanded to offer over 265 local payment methods across 60 countries. Limonetik's platform simplifies financial settlement by consolidating multiple payment flows into a single settlement, complemented by robust reconciliation and reporting tools accessible via a modern API. With over seven years of experience in the marketplace payment sector, the company processes more than $2 billion annually and supports over 14,000 merchants and marketplaces. Recognized by Gartner as a “Cool Vendor in digital commerce,” Limonetik delivers an innovative Software as a Service (SaaS) solution that significantly enhances its clients' business operations.

CAD.42

Seed Round in 2018
CAD.42 is a French company that specializes in developing a cloud-based real-time location system aimed at enhancing safety and productivity in the construction industry. The company provides innovative tools for tracking equipment and personnel on job sites, thereby improving operational workflow. Its platform includes a suite of features for safety management, productivity monitoring, and risk prediction, as well as tracking tags and a smart security vest that functions as a real-time positioning alert system. By integrating these technologies, CAD.42 enables clients to enhance safety measures, optimize productivity, and reduce costs on construction sites.

Nestor

Seed Round in 2018
Nestor is a food delivery startup that offers a streamlined daily meal service, presenting customers with a fixed menu that includes a starter, entrée, and dessert for a set price. Each day, Nestor prepares and delivers one unique meal option, ensuring that all items are cooked in-house and served hot. The company's approach emphasizes simplicity, as customers cannot customize their meals or opt out of specific items. Nestor has established a reputation for efficiency, with an average delivery time of just 13 minutes. Currently, the company delivers approximately 1,000 meals daily and is experiencing rapid growth at a rate of 15 percent per week. However, the service primarily caters to omnivorous consumers, as vegetarian options are not available.

BlockVen

Seed Round in 2018
BlockVen, founded in 2018 and based in Chatillon, France, is a venture capital firm focused on investing in early-stage projects within the blockchain, cryptocurrency, finance, and fintech sectors. The firm aims to provide professional investors with a robust investment framework for digital assets, an area that has historically lacked proper guidance. BlockVen not only invests in promising ventures but also offers advisory services to assist professionals in fundraising, launching investment products, setting up trading desks, and executing large orders related to cryptocurrency. With a team that possesses a successful track record in cryptocurrency investment and a well-established network within the EU and US cryptocurrency ecosystems, BlockVen collaborates with various industry leaders to navigate the evolving landscape of digital assets.

upOwa

Series A in 2018
upOwa is a social business that develops, deploys, and maintains innovative solar home systems in off-grid African communities. These systems provide affordable access to clean electricity, replacing traditional sources like kerosene lamps. By doing so, upOwa enables significant social and economic improvements at the community level while maintaining financial profitability and promoting environmental sustainability.

Novolyze

Seed Round in 2018
Novolyze is a company that focuses on enhancing food safety and quality for food and beverage businesses through innovative technology. It offers cloud-based solutions and microbial process validation tools that enable these companies to improve their performance and compliance in a rapidly evolving industry. By utilizing surrogate microorganisms technology, Novolyze provides specialized applications for food safety microbiology, focusing on critical equipment like steam pasteurizers, sterilizers, dryers, roasters, extruders, and ovens. The company empowers clients to achieve cleaner food production by transforming food safety and quality data into actionable insights, fostering real-time decision-making to meet the demands of modern consumers.

Acticor Biotech

Series A in 2018
Acticor Biotech SAS is a clinical-stage biopharmaceutical company based in Paris, France, founded in 2013. The company specializes in developing innovative therapeutic monoclonal antibodies aimed at treating acute thrombotic diseases, particularly focusing on acute ischemic stroke. Its lead product, Glenzocimab, is a humanized antibody designed to address the critical need for new therapeutic options in the management of stroke, a condition that affects millions globally each year and leads to significant mortality and disability. Currently, existing treatments for ischemic stroke have limited efficacy and reach, highlighting the urgent demand for more effective solutions. Acticor Biotech is dedicated to advancing its novel therapies to meet this pressing medical need.

Inqom

Series A in 2017
Inqom is a software as a service company that uses artificial intelligence to automate bookkeeping and generate real-time balance sheets. Its platform processes and enriches accounting data to deliver centralized, standardized and intelligent financial records, automating the production of accounting entries and data entry of documents. The solution can produce year-end financial statements and facilitates collaboration between entrepreneurs and chartered accountants through automated workflows.

Wandercraft

Series B in 2017
Wandercraft is a robotics company that develops self-balancing robotic exoskeletons to enable paralyzed users to stand and walk hands-free, without crutches. Its flagship exoskeleton, Atalante, is a commercial device designed for daily life and rehabilitation, CE-marked in 2019 and marketed to European rehab hospitals to support gait re-learning. The company combines algorithmics, AI, robotics, production, clinical, marketing and sales to deliver a full-stack solution and aims to bring a realistic, autonomous walking device beyond lab prototypes. The exoskeleton uses motors at each joint controlled by a computing unit running software that computes robotic algorithms every millisecond to replicate a human gait, enabling paraplegic individuals to regain autonomy during daily activities.

SmartHab

Seed Round in 2017
Founded in 2016, SmartHab specializes in developing applications to connect and control devices in residential properties. They offer solutions such as SmartHab N for new apartments and SmartHab R for student residences and renovations. The company caters primarily to real estate developers, promoters, and landlords.

Shapr

Venture Round in 2017
Shapr is a professional networking platform that connects users based on shared interests and experiences using an intelligent algorithm. Launched in the US in 2015, it has since gained traction globally, with 70% of its user base in the United States and significant presence in France and Britain. Shapr facilitates meaningful connections by presenting users with a daily selection of profiles to swipe through anonymously, notifying them when mutual interest is expressed. Users can then message within the app and arrange meetings for networking purposes. The company was founded by Ludovic Huraux, who previously created Attractive World, a premium dating site acquired by Affinitas Group. Shapr operates independently from its venture capital arm, Shapr Ventures, which invests in tech startups across various sectors excluding biotech.

Osivax

Seed Round in 2017
Osivax develops immunotherapy vaccines designed to enhance the body's immune response against infectious diseases. Their vaccines aim to expedite uptake into dendritic cells and increase immunogenicity of natural proteins, triggering a more effective immune response, including CD8 T cell activation. This enables medical practitioners to treat patients with conditions such as cancer, influenza, malaria, and other infectious diseases.

Mac Lloyd

Series A in 2017
Mac - Lloyd is the sports tracker specialist for federations, clubs, top athletes and data broadcast.

Innovorder

Series A in 2017
Founded in 2014, Innovorder specializes in digital solutions for the food service industry. Its comprehensive SaaS software suite enables deployment of new order channels, management of restaurant networks and points of sale, acceleration of order processing, optimization of production management, sales monitoring, and customer loyalty programs. Serving over 800 customers including KFC, Elior, and Compass Group, Innovorder employs more than 60 people and has raised over €10 million.

Foodvisor

Seed Round in 2017
Foodvisor is a nutrition application that aids users in adopting healthier eating habits by providing detailed nutritional information. Utilizing the camera on a smartphone, the app recognizes food items on a user's plate and estimates their serving sizes. In just seconds, it generates a comprehensive nutrition report, offering insights that go beyond simple calorie counting. This functionality empowers users to make informed dietary choices and work towards a more balanced diet. Foodvisor's innovative approach positions it as a valuable tool for individuals seeking to improve their nutrition and overall health.

Wistiki

Venture Round in 2017
Wistiki SAS is a company based in Paris, France, founded in 2013, that specializes in Bluetooth tracking technology to help users locate their belongings quickly and easily. The company's primary product, the Wistiki tracker, can be attached to various items such as keys, wallets, smartphones, and pets. When an item is misplaced, the tracker emits a ringtone, allowing the owner to locate it promptly through their smartphone. By providing a simple and effective solution for finding lost items, Wistiki aims to reduce the stress and time associated with searching for personal belongings. The company's products are available for purchase online.

OuiFlash

Seed Round in 2017
OuiFlash is an online platform that connects professional photographers with the real estate sector for various assignments. Established in 2015 and headquartered in Paris, France, the company has developed a network of image professionals across multiple countries, including France, Belgium, the United Kingdom, Germany, Spain, and the United States, among others. OuiFlash aims to enhance the value of photographers globally by providing them with opportunities tailored to the real estate market. The platform encourages the production of contemporary images while anticipating future media trends, thereby fostering innovation within the industry.

Concierge

Seed Round in 2016
Concierge is a smart button displayed in the entrance of the house. In a simple pression, Concierge takes care of the user by managing his home while he is away. He can now be free, knowing that his home is into safe hands. Concierge knows when it’s the perfect time to launch the vaccum cleaner, adjust the temperature or even switch off the forgotten light. Concierge is a smart and autonomous system where the dialogue replace the tedious configuration and the laborious setup. Its scalable fonctionalities will fit to your preferences. Concierge is like a trustful person who’s keeping you informed of every important activities of your home. Concierge gets connected with the others products to offer to the user a smart, adjustable and scalable ecosystem. Concierge is already supported by severals partners such as Parrot, Okidokeys, E-zicom, Netatmo, and much more. They want the user to build the system he truly needs, specially made for his needs. Inspired by the luxurious hotel bell, its design signed by Adrien Ciejak from Unistudio subtly fits every home. Its brushed aluminium bell makes it a singular, authentic and genuinely modern object. Its button and luminous ring display halos to keep you informed of every notable informations such as the forecasts, mail receipt or the moisture need of your favorite plant.

Acticor Biotech

Venture Round in 2016
Acticor Biotech SAS is a clinical-stage biopharmaceutical company based in Paris, France, founded in 2013. The company specializes in developing innovative therapeutic monoclonal antibodies aimed at treating acute thrombotic diseases, particularly focusing on acute ischemic stroke. Its lead product, Glenzocimab, is a humanized antibody designed to address the critical need for new therapeutic options in the management of stroke, a condition that affects millions globally each year and leads to significant mortality and disability. Currently, existing treatments for ischemic stroke have limited efficacy and reach, highlighting the urgent demand for more effective solutions. Acticor Biotech is dedicated to advancing its novel therapies to meet this pressing medical need.

Nestor

Seed Round in 2016
Nestor is a food delivery startup that offers a streamlined daily meal service, presenting customers with a fixed menu that includes a starter, entrée, and dessert for a set price. Each day, Nestor prepares and delivers one unique meal option, ensuring that all items are cooked in-house and served hot. The company's approach emphasizes simplicity, as customers cannot customize their meals or opt out of specific items. Nestor has established a reputation for efficiency, with an average delivery time of just 13 minutes. Currently, the company delivers approximately 1,000 meals daily and is experiencing rapid growth at a rate of 15 percent per week. However, the service primarily caters to omnivorous consumers, as vegetarian options are not available.

Algama

Seed Round in 2016
Algama is a pioneering food-tech company established in 2013, focused on harnessing the potential of algae to create sustainable food solutions. With a mission to feed 10 billion people by 2050 while promoting environmental sustainability, Algama specializes in developing microalgae-based products that serve as substitutes for traditional animal products, such as eggs and meat. The company also produces emulsifiers derived from algae, which are essential for formulating plant-based alternatives that mimic the taste and texture of conventional foods. Committed to innovation, Algama aims to make its ingredients and products not only delicious and affordable but also widely accessible. As a leader in the microalgae food sector, Algama actively seeks talented individuals and entrepreneurs to join its mission of transforming the food system for the better.

Mac Lloyd

Seed Round in 2016
Mac - Lloyd is the sports tracker specialist for federations, clubs, top athletes and data broadcast.

Wandercraft

Series A in 2015
Wandercraft is a robotics company that develops self-balancing robotic exoskeletons to enable paralyzed users to stand and walk hands-free, without crutches. Its flagship exoskeleton, Atalante, is a commercial device designed for daily life and rehabilitation, CE-marked in 2019 and marketed to European rehab hospitals to support gait re-learning. The company combines algorithmics, AI, robotics, production, clinical, marketing and sales to deliver a full-stack solution and aims to bring a realistic, autonomous walking device beyond lab prototypes. The exoskeleton uses motors at each joint controlled by a computing unit running software that computes robotic algorithms every millisecond to replicate a human gait, enabling paraplegic individuals to regain autonomy during daily activities.

Flashgap

Seed Round in 2015
Flashgap is a mobile application that facilitates time-delayed photo sharing, inspired by the movie 'The Hangover'. It enables users to create and contribute to photo albums tied to specific events, with a unique twist: all photos remain hidden until the following day at midday, allowing users to relive the event together. Available on iOS and Android, Flashgap caters to a younger demographic, offering both public and private album options for parties, events, or any shared experience.

Animalbox

Series A in 2015
Animalbox SARL, based in Paris, France, is a subscription box service for pets that was launched in July 2012. The company has rapidly grown to become the largest provider of monthly pet subscription boxes in Europe. Each box contains premium pet-care products, including hygiene accessories, training aids, toys, and treats, tailored to meet the needs of individual pets. In addition to its subscription offerings, Animalbox engages its community through curated content on its blog and special flash sales of pet-care products. The company operates multiple brands across France, Belgium, Switzerland, and the United Kingdom, and continues to expand its reach throughout Europe. Animalbox is supported by various investors, including Network Finances and L'Accélérateur, having successfully raised €1,500,000 to fuel its growth.

Greenkub

Seed Round in 2015
GreenKub, based in Montpellier, France, specializes in innovative modular wooden constructions. The company offers a range of products including garden studios, offices, and professional housing solutions tailored for various settings such as ski resorts and holiday villages. Utilizing locally sourced wood from across France, GreenKub provides customizable garden studios that require no building permit, allowing homeowners to maximize their land use effectively. The company emphasizes a personalized service in its turnkey offerings, catering to the unique needs of each client while promoting sustainable construction practices.

e(ye)BRAIN

Venture Round in 2015
e(ye)BRAIN SA is a medical company specializing in the development and manufacturing of eye trackers designed for the diagnosis of neurological and psychiatric diseases. Founded in 2008 and based in Paris, France, the company offers two primary products: EyeBrain T1 and EyeBrain T2. The EyeBrain T1 allows users to record eye movements, while the EyeBrain T2 incorporates advanced algorithms to capture both eye and head movements. These recorded movements are then analyzed using the MeyeEval software. In addition to its product offerings, e(ye)BRAIN provides advisory, paradigm development, training, and support services to its clients, enhancing their capabilities in clinical research and functional exploration of both healthy and diseased brains.

Wandercraft

Seed Round in 2013
Wandercraft is a robotics company that develops self-balancing robotic exoskeletons to enable paralyzed users to stand and walk hands-free, without crutches. Its flagship exoskeleton, Atalante, is a commercial device designed for daily life and rehabilitation, CE-marked in 2019 and marketed to European rehab hospitals to support gait re-learning. The company combines algorithmics, AI, robotics, production, clinical, marketing and sales to deliver a full-stack solution and aims to bring a realistic, autonomous walking device beyond lab prototypes. The exoskeleton uses motors at each joint controlled by a computing unit running software that computes robotic algorithms every millisecond to replicate a human gait, enabling paraplegic individuals to regain autonomy during daily activities.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.